FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Cardinal Health Darifenacin Extended-release Tablets 15 mg Recall

Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only, Manufactured by: Torren…

Cardinal Health Inc. · Dublin, OH

Risk level
Class II
Reported by FDA
Jun 2, 2021
Recall ID
D-0584-2021
Check your lot numberHow we source this data

Summary

Cardinal Health recalled Darifenacin Extended-release Tablets 15 mg starting Mar 15, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0584-2021 on Jun 2, 2021. Reason: CGMP Deviations: Intermittent exposure to temperature excursion during storage. Status: Terminated.

Why it was recalled

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Product description

Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only, Manufactured by: Torrent Pharmaceuticals, LTD Indrad-382 721, India Manufactured for: Torrent Pharma Inc. Basking Ridge, NJ 07920, NDC 13668-203-30

Lot numbers, UPCs & expiration codes

BDZ9G005

Where it was sold

FL, GA, SC

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0584-2021
Classification
Class II
Status
Terminated
Recall initiated
Mar 15, 2021
FDA report date
Jun 2, 2021
Quantity
37 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Cardinal Health Inc.

Original FDA data

Every field from FDA enforcement report D-0584-2021, exactly as published.

Show all FDA fields
City
Dublin
State
OH
Status
Terminated
Country
United States
Event ID
87512
Address
7000 Cardinal Pl
Code information
BDZ9G005
Postal code
43017-1091
Report date
Jun 2, 2021
Product type
Drugs
Recall number
D-0584-2021
Classification
Class II
Recalling firm
Cardinal Health Inc.
Product quantity
37 bottles
Termination date
Jun 17, 2024
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Darifenacin Extended-release Tablets 15 mg 30 Tablets Rx only, Manufactured by: Torrent Pharmaceuticals, LTD Indrad-382 721, India Manufactured for: Torrent Pharma Inc. Basking Ridge, NJ 07920, NDC 13668-203-30
Distribution pattern
FL, GA, SC
Recall initiation date
Mar 15, 2021
Initial firm notification
Letter
Center classification date
May 24, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0584-2021, published Jun 2, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls